COVID-19 declines in breast cancer screening show sociodemographic inequities
medwireNews: The declines in breast cancer screening during the COVID-19 pandemic are more marked among women from minority communities and those living in rural areas, report US researchers.
They identified an overall decrease of 49% in screening mammograms conducted during April–December 2020 relative to the same period in 2019 (n=27,522 vs 55,678 screenings) within a community healthcare system in Washington state.
When stratified by race, there were “greater and significant reductions” in screenings during 2020 versus 2019 among non-White compared with White women, report Ofer Amram (Washington State University, Spokane) and colleagues in a research letter to JAMA Network Open.
Specifically, the decreases among Hispanic, American Indian or Alaska Native, mixed race, Native Hawaiian or Pacific Islander, Asian, and Black women were 64.2%, 60.9%, 56.2%, 54.5%, 54.5%, and 53.9%, respectively, compared with a decline of 49.2% among White women.
The decline in screening during the pandemic was also significantly greater for women living in rural than urban areas, at nearly 60% and around 50%, respectively.
“Our findings suggest another inequity in the COVID pandemic due to greater reduction in utilization of cancer screening services for women with lower socioeconomic status, who are in underserved racial/ethnic groups, and live in rural communities,” concludes the team.
medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group
24 May 2021: The coronavirus pandemic is affecting all healthcare professionals across the globe. Medicine Matters’ focus, in this difficult time, is the dissemination of the latest data to support you in your research and clinical practice, based on the scientific literature. We will update the information we provide on the site, as the data are published. However, please refer to your own professional and governmental guidelines for the latest guidance in your own country.